Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro Cavallari, Financial Reporting and Risk Management Manager.
The Oscar di Bilancio, which reached its 60th edition this year, recognised HT’s commitment to drafting the Integrated Report, a fundamental tool for transparent communication of the financial and non-financial performance of organisations, in the context of sustainable growth.
The document was awarded for its clear commitment to integrating both qualitative narrative and quantitative data (KPIs) in order to offer stakeholders a comprehensive overview of activities and their alignment with sustainable development goals.
Below are the motivations that led to the awarding of HT’s Integrated Report 2023:
“The Integrated Report 2023 in a structured and rigorous manner represents “accountability” in the transition of consolidating HT’s scientific and administrative infrastructure towards the goal of research excellence. The report is readable in its key information (both strategic and operational) even to non-experts. The effort to integrate qualitative narrative and quantitative data (KPIs) is evident, with the aim of providing all stakeholders with an overall picture of the activities, their nature, and the commitment to sustainable development. The 2023 results are described in a timely, comprehensive and transparent manner, testifying to the operational focus, in terms of effectiveness and efficiency, in internal management.”
The Oscar di Bilancio, awarded by FERPI with Borsa Italiana and Bocconi University, is one of the most prestigious awards in Italy for transparency and financial communication. Created in 1954 to assess corporate financial statements, today it also rewards sustainability, ESG criteria and social responsibility, reflecting the economic and social transformations of recent decades.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.